Cyclodextrin-loaded nanobubbles reduce cholesterol and atherosclerosis in vivo
Polymeric nanobubbles were prepared by using polybutlycyanoacrylate. The incorporation of near-infrared dye (IR780) resulted in a multimodal contrast NB, which
A forum for researchers, students and applicants in the field of cyclodextrin technology
Polymeric nanobubbles were prepared by using polybutlycyanoacrylate. The incorporation of near-infrared dye (IR780) resulted in a multimodal contrast NB, which
The elevated occurrence of debilitating neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD), Alzheimer’s disease (AD), Parkinson’s
Cyclo Therapeutics, (Cyclo) a clinical stage company focused on developing therapies for rare and neurological diseases with limited treatment options,
Methylated β-cyclodextrin (MβCD) can extract cholesterol from lipid rafts and induce apoptosis in cancer cells by inhibiting activation of the
Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND), is a rare and terminal neurodegenerative disease that results
We have previously reported about a potential new neuromuscular blockade reversal agent called adamgammadex. Its structure is quite similar to
This work presents the most recent advances in the research and clinical use of HPβCD against Niemann–Pick disease, a congenital
A paradigm shift in cyclodextrin technology started with the design, development and marketing of Sugammadex®/Bridion®, and followed by designation of
Cyclodextrins (CDs) are known for their ability to extract lipid components from synthetic and biological membranes and therefore to induce
Experimental simian immunodeficiency virus (SIV) infection of Asian macaques is an excellent model for HIV disease progression and therapeutic development.